.png){kind=icon}
A
Arka De
H指数:22
被引数:2,140
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Effect of Blood Group on von Willebrand Factor Antigen Levels in Compensated Advanced Chronic Liver Disease and Utility of von Willebrand Factor- Platelet Ratio for Detecting Clinically Significant Portal Hypertension
血型对代偿期晚期慢性肝病中血管性血友病因子抗原水平的影响及血管性血友病因子-血小板比值在检测临床显著门静脉高压中的价值
Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study
AGILE 3+和AGILE 4评分在评估印度非酒精性脂肪肝病患者中晚期肝纤维化和肝硬化的有效性验证：印度非酒精性脂肪肝病研究联盟研究
Incidence, Predictors, and Course of Hepatocellular Carcinoma Following Direct-Acting Antivirals Therapy in a Prospective Genotype-3 Predominant HCV Elimination Compensated Cirrhosis Cohort
直接抗病毒药物治疗后，在前瞻性基因型-3为主的HCV清除性代偿期肝硬化队列中，肝细胞癌的发生率、预测因子和病程
Clinical Outcomes of Stereotactic Body Radiotherapy in Hepatocellular Carcinoma Patients with Child–Turcotte–Pugh B Liver Dysfunction
立体定向体部放射治疗在Child–Turcotte–Pugh B级肝功能不全的肝细胞癌患者中的临床结果
Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP-INDIA Study
肝硬化自发性细菌性腹膜炎的流行病学、抗菌药物耐药性预测因子及经验性治疗策略：一项多中心SBP-INDIA研究
EUS-guided Liver Biopsy and Portosystemic Pressure Gradient Assessment (Using Modified Non-proprietary Setup) in Patients With Suspected cACLD or Cirrhosis
超声内镜引导下肝活检及门体压力梯度评估（使用改良非专有装置）在疑似慢性肝病或肝硬化患者中的应用
Exploring role of therapeutic plasma exchange for hepatitis A-related acute liver failure: An Indian multi-center cohort study
探索血浆置换疗法在甲型肝炎相关急性肝衰竭中的治疗作用：一项印度多中心队列研究
Noncontrast abbreviated MRI demonstrates superior diagnostic accuracy compared to ultrasound for hepatocellular carcinoma detection: Interim results from a prospective surveillance trial
无对比剂缩短版MRI在肝细胞癌检测中显示出比超声更高的诊断准确性：前瞻性监测试验的初步结果
Hepatology
IF15.8
Saroglitazar for non-obese metabolic-dysfunction associated steatotic liver disease (MASLD): An open-label randomised controlled trial
Saroglitazar用于非肥胖代谢功能障碍相关脂肪性肝病（MASLD）：一项开放标签随机对照试验
Type 2 diabetes mellitus and risk of advanced fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) - The results of multi-centre Indian Consortium on MASLD (ICOM-D) Study.
2型糖尿病和代谢功能障碍相关脂肪性肝病（MASLD）患者进展性肝纤维化的风险——多中心印度MASLD研究联盟（ICOM-D）研究的结果。
Endoscopic Ultrasound-Guided Coiling Plus Glue Injection Compared With Other Endoscopic Modalities in Managing Gastric Varices: A Systematic Review and Meta-Analysis
内镜超声引导下线圈栓塞联合胶体注射与其他内镜方法在胃静脉曲张管理中的比较：一项系统评价和Meta分析
Deep learning for non-invasive detection of steatosis and fibrosis in MASLD: a multicenter study with a new fibroscan-labelled ultrasound dataset
基于超声影像标记的肝脏硬度检测数据集，对MASLD患者脂肪变性和纤维化的无创深度学习检测：一项多中心研究
ABDOMINAL RADIOLOGY
IF2.2
Corrigendum to “Clinical and pathophysiological characteristics of non-acute decompensation of cirrhosis” [J Hepatol (2025) https://doi.org/10.1016/j.jhep.2025.02.028]
勘误：“非急性肝硬变失代偿的临床和病理生理特征” [J Hepatol (2025) https://doi.org/10.1016/j.jhep.2025.02.028]
